These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7247360)

  • 21. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.
    Toivanen A; Kasan A; Sundquist H; Toivanen P
    Chemotherapy; 1976; 22(2):97-103. PubMed ID: 1253636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous trimethoprim-sulfamethoxazole alone or combined with tobramycin for infections in cancer patients.
    Grose WE; Bodey GP
    Am J Med Sci; 1980; 279(1):4-13. PubMed ID: 7369247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of trimethoprim-sulfamethoxazole resistance genes and their relatedness to class 1 integron and insertion sequence common region in gram-negative bacilli.
    Shin HW; Lim J; Kim S; Kim J; Kwon GC; Koo SH
    J Microbiol Biotechnol; 2015 Jan; 25(1):137-42. PubMed ID: 25348695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
    Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
    Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiologic features of urinary infections due to enterobacteriaceae resistant to nalidixic acid and trimethoprim.
    Light RB; Ronald AR; Harding G; Fox L; Buckwold FJ
    Scand J Infect Dis; 1981; 13(3):195-202. PubMed ID: 7313574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
    Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
    Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.
    Colgan R; Johnson JR; Kuskowski M; Gupta K
    Antimicrob Agents Chemother; 2008 Mar; 52(3):846-51. PubMed ID: 18086847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.
    Greenwood D; O'Grady F
    J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates.
    Jackson-York GL; Gump BB; Gump DW
    J Antimicrob Chemother; 1983 Nov; 12(5):515-8. PubMed ID: 6671927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of trimethoprim-sulfamethoxazole in gonococcal infections.
    Austin TW; Holmes KK
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):37-9. PubMed ID: 805648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
    Hamilton DJ; Ulness BK; Baugher LK; Counts GW
    J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
    Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
    Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection.
    Pearson NJ; Towner KJ; McSherry AM; Cattell WR; O'Grady F
    Lancet; 1979 Dec; 2(8154):1205-8. PubMed ID: 92620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial Resistance and Urinary Tract Infection Recurrence.
    Nelson CP; Hoberman A; Shaikh N; Keren R; Mathews R; Greenfield SP; Mattoo TK; Gotman N; Ivanova A; Moxey-Mims M; Carpenter MA; Chesney RW
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26969273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora.
    Stamey TA; Condy M; Mihara G
    N Engl J Med; 1977 Apr; 296(14):780-3. PubMed ID: 320482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
    Kamme C; Melander A; Nilsson NI
    Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
    Raz-Pasteur A; Liron Y; Amir-Ronen R; Abdelgani S; Ohanyan A; Geffen Y; Paul M
    J Glob Antimicrob Resist; 2019 Jun; 17():168-172. PubMed ID: 30557685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
    Gotuzzo E; Oberhelman RA; Maguiña C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.